Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(33%)

Phase Distribution

Ph phase_3
2
67%
Ph phase_1
1
33%

Phase Distribution

1

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 3Large-scale testing
2(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Terminated(1)
Other(1)

Detailed Status

unknown1
Terminated1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
50.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (33.3%)
Phase 32 (66.7%)

Trials by Status

unknown133%
terminated133%
completed133%

Recent Activity

0 active trials
Showing 3 of 3
terminatedphase_3

Effect of Fecal Microbiota Transplantation (FMT) in Pediatric Functional Gastrointestinal Disorders

NCT05753774
completedphase_3

A Comparison of Recovery After Impacted Wisdom Tooth Removal

NCT07304882
unknownphase_1

Adipose Mesenchymal Stem Cells (AMSC) for Treatment of Ulcerative Colitis

NCT03609905

Clinical Trials (3)

Showing 3 of 3 trials
NCT05753774Phase 3

Effect of Fecal Microbiota Transplantation (FMT) in Pediatric Functional Gastrointestinal Disorders

Terminated
NCT07304882Phase 3

A Comparison of Recovery After Impacted Wisdom Tooth Removal

Completed
NCT03609905Phase 1

Adipose Mesenchymal Stem Cells (AMSC) for Treatment of Ulcerative Colitis

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3